ES2134284T3 - Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos. - Google Patents
Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.Info
- Publication number
- ES2134284T3 ES2134284T3 ES94105958T ES94105958T ES2134284T3 ES 2134284 T3 ES2134284 T3 ES 2134284T3 ES 94105958 T ES94105958 T ES 94105958T ES 94105958 T ES94105958 T ES 94105958T ES 2134284 T3 ES2134284 T3 ES 2134284T3
- Authority
- ES
- Spain
- Prior art keywords
- pirimidindionas
- pirido
- medicines
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
UN COMPUESTO DE LA FORMULA I Y/O LAS SALES TOLERABLES FISIOLOGICAMENTE DEL COMPUESTO DE LA FORMULA I Y/O EVENTUALMENTE FORMAS ESTEREOISOMERAS DEL COMPUESTO DE LA FORMULA I, QUE SON APROPIADOS PARA LA ELABORACION DE MEDICAMENTO PARA TRATAMIENTO DE PERTURBACIONES DE LA CIRCULACION SANGUINEA Y/O ENFERMEDADES NEURODEGENERATIVAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4313317 | 1993-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2134284T3 true ES2134284T3 (es) | 1999-10-01 |
Family
ID=6486199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94105958T Expired - Lifetime ES2134284T3 (es) | 1993-04-23 | 1994-04-18 | Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5556854A (es) |
EP (1) | EP0621037B1 (es) |
JP (1) | JP3483160B2 (es) |
AT (1) | ATE181832T1 (es) |
DE (1) | DE59408453D1 (es) |
DK (1) | DK0621037T3 (es) |
ES (1) | ES2134284T3 (es) |
GR (1) | GR3031267T3 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ334389A (en) * | 1996-08-28 | 2001-05-25 | Ube Industries | Cyclic amine derivatives |
WO1999043648A1 (fr) | 1998-02-27 | 1999-09-02 | Sankyo Company, Limited | Composes amino cycliques |
TW546302B (en) * | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
PA8539401A1 (es) * | 2001-02-14 | 2002-10-28 | Warner Lambert Co | Quinazolinas como inhibidores de mmp-13 |
US6825180B2 (en) * | 2001-05-18 | 2004-11-30 | Cell Therapeutics, Inc. | Pyridopyrimidine compounds and their uses |
DE60330485D1 (de) * | 2002-07-15 | 2010-01-21 | Merck & Co Inc | Zur behandlung von diabetes |
US9567331B2 (en) | 2011-11-15 | 2017-02-14 | Trustees Of Boston University | Pyridopyrimidinone inhibitors of viruses |
WO2018031990A1 (en) * | 2016-08-12 | 2018-02-15 | Nanjing Gator Meditech Company, Ltd. | Protein kinase regulators |
EP3930714A4 (en) | 2019-02-27 | 2022-10-26 | Madera Therapeutics, LLC | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA762455A (en) * | 1962-03-22 | 1967-07-04 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyrido-pyrimidines |
-
1994
- 1994-04-18 DK DK94105958T patent/DK0621037T3/da active
- 1994-04-18 AT AT94105958T patent/ATE181832T1/de active
- 1994-04-18 EP EP94105958A patent/EP0621037B1/de not_active Expired - Lifetime
- 1994-04-18 ES ES94105958T patent/ES2134284T3/es not_active Expired - Lifetime
- 1994-04-18 DE DE59408453T patent/DE59408453D1/de not_active Expired - Lifetime
- 1994-04-21 US US08/230,811 patent/US5556854A/en not_active Expired - Lifetime
- 1994-04-22 JP JP10630594A patent/JP3483160B2/ja not_active Expired - Fee Related
-
1999
- 1999-09-22 GR GR990402365T patent/GR3031267T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0621037A1 (de) | 1994-10-26 |
JP3483160B2 (ja) | 2004-01-06 |
JPH06321944A (ja) | 1994-11-22 |
EP0621037B1 (de) | 1999-07-07 |
DK0621037T3 (da) | 2000-01-17 |
GR3031267T3 (en) | 1999-12-31 |
DE59408453D1 (de) | 1999-08-12 |
US5556854A (en) | 1996-09-17 |
ATE181832T1 (de) | 1999-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI940072A0 (fi) | Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
NO179867C (no) | Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler | |
FI925549A (fi) | Nya azaheterocyklylmetyl-kromaner | |
CS145091A3 (en) | Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application | |
NO306464B1 (no) | Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter | |
ES2064130T3 (es) | Utilizacion de droloxifeno para el tratamiento de enfermedades de los huesos. | |
DE3382641T2 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
DE3679920D1 (de) | Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel. | |
DE68917485T2 (de) | Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen. | |
ES2076226T3 (es) | Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas. | |
ES2134284T3 (es) | Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos. | |
ATE141605T1 (de) | Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen | |
ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
AU670491C (en) | Pharmaceutical for the treatment of skin disorders | |
MX9205869A (es) | Triazaspirodecanon-metilcromanos, procedimiento para su fabricacion y medicamento que los contiene. | |
DE3872425D1 (de) | Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel. | |
NO306468B1 (no) | Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse | |
GR3037039T3 (en) | Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants. | |
ES528323A0 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
MX9102181A (es) | Iminobenzodiazepina para el tratamiento de desordenes del sueno | |
ES2034041T3 (es) | Acido n-carbotoxi-4-tiazolidin-carboxilico, proceso para su preparacion y su uso como medicamento. | |
NO924472D0 (no) | Nikotinylalanin som terapeutisk middel med virkning paa sentralnervesystemet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 621037 Country of ref document: ES |